Laura Deming on reversible cryopreservation
Deming explains Until’s engineering approach to cryopreservation, the challenges of organ preservation, and the team’s research goals.
1 unread notifications
Laura Deming is the co-founder and CEO of Until, which develops reversible cryopreservation systems for human organs. She is also a co-founder and venture partner at age1, a fund backing early-stage longevity biotechnology companies, and previously founded The Longevity Fund.
Laura Deming is the co-founder and CEO of Until, which develops reversible cryopreservation systems for human organs. She is also a co-founder and venture partner at age1, a fund backing early-stage longevity biotechnology companies, and previously founded The Longevity Fund.
Career
Cosigns Received
Eric WeinsteinThe Portal host; former Thiel Capital managing director
Laura Deming, for example, blew me away… she had some of the best insights.